Orthopaedic Implants Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2016-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Orthopaedic Implants Market: By Application (Spinal fusion, Long bone, Foot & Ankle, Craniomaxillofacial, Joint replacement, Dental)By Types (Pins, Rods, Screws)By End Users( Hospitals, Clinics, Homecare) By Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Orthopaedic Implants Market size was valued at USD 46.6 billion in 2021. It is expected to reach a value of USD 64.1 billion by 2028, growing at a CAGR of 4.2% during 2022-2028. The orthopaedic implant is used to replace a joint, bone, or cartilage that has been damaged or deformed due to an injury or congenital condition, such as breaking a leg. To prevent the body from rejecting orthopaedic implants, the material utilised must be biocompatible. Another concern with orthopaedic implants is that they could come free or break in the bone, inflicting excruciating agony and infection on the tissue around them.

 

Orthopaedic Implants Market

MARKET SUMMARY
-
4.2%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 4.2%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Orthopaedic Implants Market

  • Orthopaedic Implants Market gives historical, current, and future market sizes (US$ Bn) of product type and distribution channel and geographic regions.
  • This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market.
Key Players

 

  • Stryker Corporation
  • NuVasive, Inc.
  • Medtronic, Inc.
  • LifeNet Health, Inc.
Orthopaedic Implants Market Dynamics

As indicated by the WHO, the normal age of the total populace was 37.3 years in 2000 and is foreseen to achieve 45.5 years by 2050. Owing to lifestyle-related factors like early burnout and absence of activity, patients in their middle-age are progressively deciding on orthopedic inserts. The orthopedic implants market is development driven. In this manner, item advancement through broad innovative work exercises, acquisitions, and joint efforts are a portion of the systems executed bythe players to extend their piece of the overall industry. For example, In June 2015, Zimmer Holdings, Inc. procured Biomet, Inc. The synergistic powers of both joined as a solitary element, ZimmerBiomet Holdings, Inc., now furnished with a consolidated item portfolio has brought about its reinforced position in the musculoskeletal market.


North-America Got Significant Share

Orthopaedic Implants Market

Geographically Orthopaedic Implants Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America overwhelmed the orthopedic implants market due to the rise in geriatric populace check accordingly expanding the quantity of patients experiencing osteoarthritis and osteoporosis. Furthermore, the continuous change toward insignificantly intrusive methodology is foreseen to push forward the market development in the North America locale. China, India, and Brazil are foreseen to enroll the quickest development during the forecast period. Factors responsible for the significant growth of the market in these countries includes the developing patient mindfulness levels identified with the business accessibility of the orthopedic implants, increasing medical tourism, and the continually enhancing medicinal services. Therefore, Asia Pacific and Latin America are foreseen to indicate huge development in orthopedic implants market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Orthopaedic Implants Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.


Report

Table Of Content


Report

Company Profile

Market participants: Orthopaedic Implants Market 

Some of the players in Orthopaedic Implants Market

  • Olympus Corporation (Olympus Biotech Corporation) (Japan)
  • Wright Medical Group, Inc. (BioMimetic Therapeutics) (U.S.)
  • Johnson & Johnson Services, Inc. (DePuy Synthes) (U.S.)
  • Stryker Corporation (U.S.)
  • Regeneration Technologies, Inc.(U.S)
  • NuVasive, Inc. (U.S.)
  • NovaBone Products (U.S)
  • Medtronic, Inc.(U.S.)
  • LifeNet Health, Inc. (U.S.)
  • Zimmer Biomet (Biomet, Inc.) (U.S.)

Description

Orthopaedic Implants Market size was valued at USD 46.6 billion in 2021. It is expected to reach a value of USD 64.1 billion by 2028, growing at a CAGR of 4.2% during 2022-2028. The orthopaedic implant is used to replace a joint, bone, or cartilage that has been damaged or deformed due to an injury or congenital condition, such as breaking a leg. To prevent the body from rejecting orthopaedic implants, the material utilised must be biocompatible. Another concern with orthopaedic implants is that they could come free or break in the bone, inflicting excruciating agony and infection on the tissue around them.

 

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX